Jepchirchir’s 3‑Minute Lead Turns Into an EPO Plot Twist

Peres Jepchirchir surged to the finish of the 2026 Sydney Marathon with a three‑minute advantage, becoming the first woman to cross the line in the race.

A post‑race laboratory analysis, however, detected the presence of erythropoietin (EPO) in her sample, prompting the sport’s governing body to issue a provisional suspension.

The provisional ban will stay in effect while a full investigation is carried out, meaning her victory remains under a cloud of uncertainty.

The development adds a dramatic twist to what was otherwise a historic win for Kenyan long‑distance running.

Sydney’s iconic harbour backdrop now hosts a story that is as much about a lab report as it is about a finish line.